Skip to search formSkip to main contentSkip to account menu

empagliflozin

Known as: (1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol, 1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Introduction of computer-assisted analysis to pharmaceutical products is considered a significant approach. A new method was… 
2016
2016
TO THE EDITOR: The study by Pritchard et al. (Aug. 4 issue)1 has major implications for translational science, and it provides… 
2016
2016
Aims/hypothesisSodium glucose co-transporter 2 (SGLT2) inhibitors lower glycaemia by inducing glycosuria, but raise endogenous… 
2016
2016
More than 10 million Canadians are currently living with diabetes.[1][1] Of those, 90% have type 2 diabetes mellitus (T2DM).[1][1… 
2014
2014
Empagliflozin, (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol…